Summitry LLC’s Bio-Techne TECH Stock Holding History

Summitry LLC’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$432K	Buy	6,120 +107	+2%	+$5.78K	0.01%	178
2026 Q1	$314K	Buy	6,013 +879	+17%	+$52.8K	0.01%	201
2025 Q4	$302K	Buy	5,134 +829	+19%	+$50.4K	0.01%	176
2025 Q3	$239K	Buy	+4,305	New	+$231K	0.01%	181

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Summitry LLC's TECH Position: Q2 2026 in Review

Summitry LLC increased its Bio-Techne (TECH) stake by 1.8% in Q2 2026, buying an estimated $5.78K and bringing the position to 6,120 shares worth $432K. The position accounts for 0.01% of the portfolio, ranked #178.

Summitry LLC first reported a position in TECH in Q3 2025 and has held it in 4 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Summitry LLC held 6,120 shares of Bio-Techne worth $432K as of Q2 2026.
Summitry LLC bought 107 Bio-Techne shares in Q2 2026, an estimated $5.78K.
Bio-Techne made up 0.01% of Summitry LLC's portfolio in Q2 2026, its #178 holding.
Summitry LLC first reported a position in Bio-Techne in Q3 2025 and has held it in 4 quarters since.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.